Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.atherosclerosis.2016.05.012 | DOI Listing |
Publication Analysis
Top Keywords
corrigendum "rvx-208
4
"rvx-208 bet-inhibitor
4
bet-inhibitor treating
4
treating atherosclerotic
4
atherosclerotic cardiovascular
4
cardiovascular disease
4
disease raises
4
raises apoa-i/hdl
4
apoa-i/hdl represses
4
represses pathways
4
Similar Publications
Corrigendum to "RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease" [Atherosclerosis 247 (2016) 48-57].
Atherosclerosis
October 2016
Resverlogix Corp., Calgary, Canada. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!